Journal of Cell Science & Therapy
Open Access

International Conference on Emerging Cell Therapies

October 1-3, 2012 DoubleTree by Hilton Chicago-North Shore, USA

Scientific Tracks Abstracts

• Use of a reporter iPS cell line to generate RPE tissues

  Kapil Bharti

  PDF HTML

• Novel integrative nuclear signaling module for neuronal development and regenerative medicine

  Michal K. Stachowiak

  PDF HTML

• Neuroprotection: One cell at a time

  Brian Sims

  PDF HTML

• Advances in stem cell technology-hESC-derived beta-cells as a source for diabetes therapy

  Christian X. Andersson

  PDF HTML

• Telocytes & stem cells: An emerging cardiac cell therapy

  Laurentiu M. Popescu

  PDF HTML

• Translational development of enhanced potency cellular therapies

  Madhusudan V. Peshwa

  PDF HTML

• Adoptive cell therapy of cancer and autoimmune diseases employing genetically T cells with redirected antibody specificity

  Zelig Eshhar

  PDF HTML

• Stem cell-based therapy for dry AMD

  Nady Golestaneh

  PDF HTML

• Small molecule lineage-specification of pluripotent human embryonic stem cells and its implication for the future of stem cell therapy

  Xuejun H. Parsons

  PDF HTML

• PPAR? in vascular smooth muscle cells counteracts LRP1-induced vascular calcification by inhibiting a WNT5a signaling pathway

  Philippe Boucher

  PDF HTML

• Modulation of micro RNA/RNAi pathway

  Yujing Li

  PDF HTML

• Towards in situ photoreceptor replacement in the mammalian eye

  Shu-Zhen Wang

  PDF HTML

• Necrosis-associated factors (DAMPs) like S100A4 used to pulse dendritic cells (DCs) enhance the proliferative lymphocyte response

  Ramin Lotfi

  PDF HTML

• A friedreich’s ataxia neuronal cell model with evidence of oxidative stress-mediated neurodegeneration

  Barbara Carletti

  PDF HTML

• Association between RANTES gene -28C/G polymorphism and allergic diseases among Egyptian children

  Yousri M. Hussein

  PDF HTML

• The mucosal immune response to plant-derived biopharmaceuticals

  Kathleen L. Hefferon

  PDF HTML

• Glycans in dendritic cells function and cancer progression

  Videira P. A

  PDF HTML

• Differentiation of CD34+ cells using small activating RNA targeting the islet �-cell transcriptional factor MafA

  Nagy A. Habib

  PDF HTML

• Leveraging natural compounds for network based anti-cancer medicine of oral cancer therapy

  Prakash S Bisen

  PDF HTML

• Translating the p53 pathway into drug discovery

  Hua Lu

  PDF HTML

• Histopathological changes in male wistar rats maintained on a water-based Sutherlandia frutescencs extract

  Nicolas Wickens

  PDF HTML

• Molecular basis of epigenetic inheritance

  Fei Li

  PDF HTML

• Direct reprogramming of human astrocytes to dopaminergic neurons

  Russell C. Addis

  PDF HTML

• Do mesenchymal stem cells and other similar adult stem cells home to tumors where they favor tumor growth: If so, can we use them in clinical trials safely?

  Frank C Marini

  PDF HTML

• Therapeutic potential of naive and genetically modified mesenchymal stem cells for traumatic brain injury

  Aleksandra Glavaski-Joksimovic1, Martha C. Bohn2 and Dorothy A. Kozlowski3

  PDF HTML

• Hypoxia promotes satellite cell self-renewal and enhances the efficiency of myoblast transplantation

  Shihuan Kuang

  PDF HTML

• TNIIIA2, a Tenascin-C-derived peptide, modulates tumor cell survival, proliferation and differentiation: Implication of ß 1-integrin activation in cell regulation

  Takuya Iyoda

  PDF HTML

• Development of new strategies for non-viral gene delivery: Exploring the microtubule retrograde transport

  Adriano R. Azzoni

  PDF HTML

• Precision genome editing with engineered nucleases

  Jin-Soo Kim

  PDF HTML

• Tissue engineering approach to cell delivery

  Deepa Ghosh

  PDF HTML

• Potential of hematopoeitic stem cells for skin regeneration in resistant burn wound

  Manal Eid and Hesham Fathy

  PDF HTML

• Manal Eid and Hesham Fathy

  Michel N. Mifundu

  PDF HTML

• Mechanism and prevention of tau oligomer toxicity in alzheimer’s disease

  Kristina R. Patterson

  PDF HTML

• Evaluation of effective oncogenic transcription factors in oral squamous cell carcinoma for future therapeutic invention

  Govindaraju Yedida

  PDF HTML

• Cells as delivery vehicles for anti-cancer therapeutics

  Deryl Troyer

  PDF HTML

• Oral administration of Fe-bLf loaded nanocapsules for colon cancer therapy

  Jagat Kanwar

  PDF HTML

• Protein kinase braf inhibitors as targeted therapy for border line epithelial ovarian tumors

  Samir A. Farghaly

  PDF HTML

• Targeted alpha therapy for cancer & the use of radioisotopes

  Graeme Melville

  PDF HTML

• Bcl-2 Antagonists: Targeted therapeutics in chronic lymphocytic leukemia

  Kumudha Balakrishnan

  PDF HTML

• Use of zebrafish embryos to elucidate and target disease mechanisms in vivo

  Jan de Sonneville

  PDF HTML

• Benign diffuse gastric mucosal disease: Generic and content challenges

  Hassan Fadlalla Ahmed Ali

  PDF HTML

• Racial disparities in hexokinase 2 (HK2) expression in hepatocellular carcinoma (HCC)

  Grace Guzman

  PDF HTML

• FOXP3 expression during the development of a murine melanoma

  Moises Armides Franco Molina

  PDF HTML

• Impact of DAMPs, and specifically HMGB1, on the biology of mesenchymal stromal cells within injured/necrotic tissue

  Ramin Lotfi

  PDF HTML

• Investigation of shikonin as a novel scar remediation therapy

  Yan Xie, Chen Fan, Ying Dong, Emily Lynam, Kun Li, Yonghua Su and Zee Upton

  PDF HTML

• Quinuclidinone derivatives induced apoptosis in human breast cancer cells via sphingomyelinase and JNK signaling

  Ahmed Malki

  PDF HTML

• Safety and efficacy of repeated infusions of Celyvir in children with metastatic neuroblastoma

  Esther Rincon

  PDF HTML

• Differential antiproliferative properties of 17ß-estradiol analog in combination with dichloroacetic acid on human breast cancer MCF-7 and non-tumorigenic MCF-12A cells

  Xiao Xing Stander

  PDF HTML

• Adoptive cell therapy of autoimmune diseases employing genetically T- regulatory cells with redirected antibody specificity

  Zelig Eshhar

  PDF HTML

• Embryonic vs. Induced pluripotent stem cells: Considerations for clinical applications

  Vasil Galat

  PDF HTML

• New generations improved detection via nano microfluidics-based devices and nanodelivery to colon cancer therapy

  Jagat Kanwar

  PDF HTML

• Developing cell therapy products for commercial use

  Kristin Comella

  PDF HTML

• Autologous cord blood infusions for the treatment of pediatric neurological conditions

  David T. Harris

  PDF HTML

• Clinical development of multistem® for treatment of CNS injury and disease

  Robert W. Mays

  PDF HTML

• Iron-containing nanoparticles for cell-mediated hyperthermia

  Stefan H. Bossmann

  PDF HTML

• Repair of critical-sized cartilage defects with engineered constructs generated without cell expansion

  Stephen D. Waldman

  PDF HTML

• Preclinical experience and perspectives of a clinical trial using cd133 stem cells

  Torrente Y

  PDF HTML

• Selective photodynamic therapy based on aggregation-induced emission enhancement two- photon absorbing nanoparticles

  Cheng-Chung Chang

  PDF HTML

• EGFR antibody conjugated mesoporous silica nanoparticles for cytosolic phospholipase A2 targeted nonsmall lung cancer therapy

  S. Sundarraj

  PDF HTML

• Potential therapies for muscular dystrophy

  Morayma Reyes

  PDF HTML

• Risk reduction in cell therapy

  Randy Yerden

  PDF HTML

• Automated microinjection of cell-polymer suspensions in 3D ECM scaffolds for highthroughput quantitative cancer invasion screens

  Jan de Sonneville

  PDF HTML

• Technical challenges to track in vivo therapeutic cells with imaging

  Claire Billotey

  PDF HTML

• 3D model of thrombopoiesis

  Alessandra Balduini

  PDF HTML